Grace Therapeutics, Inc. (GRCE) Deferred Tax Assets, Operating Loss Carryforwards

Grace Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards

Grace Therapeutics, Inc. (GRCE) had Deferred Tax Assets, Operating Loss Carryforwards of $51.13 million as of 2026-03-31, per its 10-K filed 2026-06-18.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-18

• 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards $51.13M.
• 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards $43.05M.
• 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards $40.66M.
• 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards $38.63M.